IZ
Izotropic Corporation
IZOZF · OTC
$0.13 -1.92% (-$0.00)
1M -20.19%
Market Cap $12.8M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0.12
6.0% downside
Current Price
$0.13
Undervalued Fair Value Overvalued
According to Bulios Fair Price, IZOZF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
1/9Valuation
-
N/A EV/EBITDA N/A
P/S N/A
P/B N/A
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
57 /100
Average ROA 850.73%
Asset turnover 0.00x
ROIC 50.58%
Debt
0 /100
High Int. coverage -3.09x
Current ratio 0.02x
Net debt/EBITDA N/A
Stability
1 /100
Unstable EPS volatility 83.09%
Profitable years 0
Beta 2.42x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about IZOZF
Online
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Robert Louis Thast
Employees
5
Headquarters
Surrey